If you’re into the world of cannabis, you’ve probably heard of CBD or Cannabidiol and its derivatives (CBD oil, edibles, capsules, skincare products, even coffee…). Unlike THC, CBD by itself isn’t psychoactive, which is why it is sold now in many countries in the world without any legal prohibition.
Our favorite CBD Strains
Nowadays, due to the popularity that CBD is earning in the last few years, you can go to a cannabis club and get strains that were breed focusing only in the CBD compounds, leaving out almost entirely the THC part of the plant, getting a perfect product for those who are searching for the therapeutic and relaxing benefits of cannabidiol in a smoke.
CBD Amnesia Haze: Is a Sativa-dominant strain that was designed to bring the many benefits of original Amnesia closer to occasional and regular users alike.
CBD Mango Haze: The strain has been selectively bred to produce a high CBD content, so the large dose of CBD is accompanied by little psychoactive high.
White Widow: Technically, White Widow is not a high-CBD strain but was bred with the optimal amount of CBD as a buffer (1-4%) to mitigate some of the effects of THC.
CBD Critical Mass: A high-CBD cross of Afghani and Skunk #1, this Indica-dominant strain is great for relaxing and easing physical discomfort. It stimulates creativity and euphoria without knocking you out.
ACDC: This cannabis is a Sativa-dominant CBD with an extremely CBD-heavy cannabinoid makeup (THC:CBD ratio of 1:20), produces few if any intoxicating effects. It helps many patients treat pain, anxiety, epilepsy, multiple sclerosis, and the negative effects of chemotherapy.
CBD or cannabidiol is the second-most prevalent cannabinoid. As with much cannabis research, there is still much to learn about this incredible compound. CBD produces effects in the body that treats pain, seizures, addiction, and anxiety, just to name a few. CBD is a confirmed safe, gentle and effective treatment for nociceptive and neuropathic pain.
Another compelling area of research is around the treatment of seizures. The FDA last year approved a medication derived from cannabis to treat two rare forms of epilepsy.